THE EFFECT OF CYCLOOXYGENASE-2 INHIBITION ON ANALGESIA AND SPINAL FUSION
The DOI matches its Crossref record.
Abstract
BACKGROUND: Cyclooxygenase (COX)-2-specific inhibitors demonstrate analgesic efficacy comparable with that of conventional nonsteroidal anti-inflammatory drugs but are associated with reduced gastrointestinal side effects and an absence of antiplatelet activity. Thus, they can be administered to patients undergoing spinal fusion surgery without an added risk of bleeding. However, concerns regarding a possible deleterious effect on bone-healing have limited their routine use. Celecoxib, a COX-2 inhibitor, recently was approved for the treatment of acute pain. The goals of the present study were to examine the analgesic efficacy of celecoxib and to determine the incidence of nonunion at one year following spinal fusion surgery. METHODS: Eighty patients who were scheduled to undergo spinal fusion received either celecoxib or placebo one hour before the induction of anesthesia and every twelve hours after surgery for the first five postoperative days. Pain scores and morphine use were recorded one hour after arrival in the post-anesthesia care unit and at four, eight, twelve, sixteen, twenty, and twenty-four hours later. Intraoperative blood loss was recorded. The status of the fusion was determined radiographically at the time of the one-year follow-up. RESULTS: There were no differences in demographic data or blood loss between the two groups. Pain scores were lower in the celecoxib group at one, four, eight, sixteen, and twenty hours postoperatively. There were no differences between the two groups with regard to the pain scores at twelve and twenty-four hours postoperatively. Morphine use was lower in the celecoxib group at all postoperative time-intervals. There was no difference between the celecoxib group and the placebo group with regard to the incidence of nonunion at the time of the one-year follow-up (7.5% [three of forty] compared with 10% [four of forty]). CONCLUSIONS: The perioperative administration of celecoxib resulted in a significant reduction in postoperative pain and opioid use following spinal fusion surgery. In addition, the short-term administration of this COX-2-specific non-steroidal anti-inflammatory drug had no apparent effect on the rate of nonunion at the time of the one-year follow-up.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Fischer, H. B. J., Simanski, C. J. P., Sharp, C., Bonnet, F., Camu, F., Neugebauer, E. A. M., Rawal, N., Joshi, G. P., Schug, S. A., & Kehlet, H. (2008) · Anaesthesia · doi:10.1111/j.1365-2044.2008.05565.x · Cited by 300
Pharmacological agents and impairment of fracture healing: What is the evidence?
Pountos, I., Georgouli, T., Blokhuis, T. J., Pape, H. C., & Giannoudis, P. V. (2008) · Injury · doi:10.1016/j.injury.2007.10.035 · Cited by 168
Practical management: Nonsteroidal antiinflammatory drug (NSAID) use in athletic injuries
Mehallo, C. J., Drezner, J. A., & Bytomski, J. R. (2006) · Clinical Journal of Sport Medicine · doi:10.1097/00042752-200603000-00015 · Cited by 147
Effects of cyclooxygenase inhibition on bone, tendon, and ligament healing
Radi, Z. A., & Khan, N. K. (2005) · Inflammation Research · doi:10.1007/s00011-005-1367-4 · Cited by 113
“Rofecoxib and naproxen impaired bone in-growth in rabbit tibia at comparable levels, while ketorolac, another non-selective NSAID, impaired bone fracture healing in rats to a greater extent then did the selective COX-2 inhibitor, parecoxib (valdecoxib prodrug), which caused only a minor delay in fracture healing at do…”
BackgroundReporting of article retractions in bibliographic databases and online journals.
Wright, K., & McDaid, C. (2011) · Journal of the Medical Library Association : JMLA · doi:10.3163/1536-5050.99.2.010 · Cited by 48
Metadata
- Authors
- REUBEN, S. S., & EKMAN, E. F.
- Venue
- The Journal of Bone and Joint Surgery-American Volume
- Published
- 2005-03
- Volume
- 87
- Issue
- 3
- Pages
- 536-542
- ISSN
- 0021-9355 (ISSN-L)
- OpenAlex
- W1969342736
- Cited by
- 112
- References
- 0
- FWCI
- 15.88
- Type
- journal article
- Language
- en
- Status
- Retracted
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: THE EFFECT OF CYCLOOXYGENASE-2 INHIBITION ON ANALGESIA AND SPINAL FUSION. https://app.cochat.ai/papers/10.2106/00004623-200503000-00009
- The paper
- REUBEN, S. S., & EKMAN, E. F. (2005). THE EFFECT OF CYCLOOXYGENASE-2 INHIBITION ON ANALGESIA AND SPINAL FUSION. The Journal of Bone and Joint Surgery-American Volume. https://doi.org/10.2106/00004623-200503000-00009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.